Parvus Therapeutics Overview
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
Parvus Therapeutics General Information
Description
Developer of proprietary pMHC nanomedicine drug candidates designed to trigger the in vivo generation of antigen-specific regulatory T cells (Tregs). The company offers novel drug candidates that restore organ-specific immune tolerance, enabling patients with autoimmune diseases to potentially halt and cure their condition while preserving normal immune function.
Contact Information
Website
www.parvustx.comCorporate Office
- 256 East Grand Avenue 103
- South San Francisco, CA 94080
- United States
Corporate Office
- 256 East Grand Avenue 103
- South San Francisco, CA 94080
- United States
Parvus Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 01-Feb-2026 | Completed | Clinical Trials - Phase 1 | |||
| 5. Later Stage VC | 20-Mar-2024 | Completed | Clinical Trials - Phase 1 | |||
| 4. Corporate | 16-May-2019 | Completed | Clinical Trials - Phase 1 | |||
| 3. Corporate | 19-Apr-2017 | Completed | Clinical Trials - Phase 1 | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Grant | 30-Jul-2009 | $222K | Completed | Startup |
Parvus Therapeutics Signals
Parvus Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AbbVie Ventures | Corporate Venture Capital | Minority | ||
| Genentech | Corporation | Minority | ||
| Novartis | Corporation | Minority |
Parvus Therapeutics FAQs
-
Where is Parvus Therapeutics headquartered?
Parvus Therapeutics is headquartered in South San Francisco, CA.
-
What is the size of Parvus Therapeutics?
Parvus Therapeutics has 22 total employees.
-
What industry is Parvus Therapeutics in?
Parvus Therapeutics’s primary industry is Drug Discovery.
-
Is Parvus Therapeutics a private or public company?
Parvus Therapeutics is a Private company.
-
What is Parvus Therapeutics’s current revenue?
The current revenue for Parvus Therapeutics is .
-
Who are Parvus Therapeutics’s investors?
AbbVie Ventures, Genentech, and Novartis have invested in Parvus Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process